| scholarly article | Q13442814 |
| P356 | DOI | 10.1155/2012/312817 |
| P953 | full work available online at | http://downloads.hindawi.com/journals/ad/2012/312817.pdf |
| http://downloads.hindawi.com/journals/ad/2012/312817.xml | ||
| https://downloads.hindawi.com/journals/ad/2012/312817.pdf | ||
| https://europepmc.org/articles/PMC3530748 | ||
| https://europepmc.org/articles/PMC3530748?pdf=render | ||
| P932 | PMC publication ID | 3530748 |
| P698 | PubMed publication ID | 23304455 |
| P5875 | ResearchGate publication ID | 234100078 |
| P2093 | author name string | Hind I. Fallatah | |
| Hisham O. Akbar | |||
| P2860 | cites work | Orvosi Hetilap | Q550234 |
| The Lancet | Q939416 | ||
| Journal of Clinical Investigation | Q3186904 | ||
| Indian Journal of Medical Sciences | Q6020790 | ||
| Mayo Clin Proc | Q6538184 | ||
| The American Journal of Gastroenterology | Q7713501 | ||
| Polski Tygodnik Lekarski | Q11822592 | ||
| Asian Pacific Journal of Allergy & Immunology | Q13430713 | ||
| Hepato-Gastroenterology | Q15752074 | ||
| Comparative Hepatology | Q15760004 | ||
| Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis | Q22008795 | ||
| Autoimmune liver serology: current diagnostic and clinical challenges | Q24644140 | ||
| Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis | Q24681787 | ||
| Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease | Q24804699 | ||
| Autoimmune hepatitis in India: profile of an uncommon disease | Q24816619 | ||
| Cellular and Molecular Immunology | Q26842256 | ||
| Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection | Q27480696 | ||
| Severe, acute liver injury and khat leaves | Q84126860 | ||
| Autoimmune hepatitis | Q84136180 | ||
| Treatment of autoimmune hepatitis | Q84395796 | ||
| Seven cases of autoimmune hepatitis that developed after drug-induced liver injury | Q84498995 | ||
| Anti TNF-alpha therapy can be a novel treatment option in patients with autoimmune hepatitis | Q84514977 | ||
| Clinical presentation, response to therapy, and predictors of fibrosis in patients with autoimmune hepatitis in Saudi Arabia | Q84787013 | ||
| Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis | Q42989153 | ||
| Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. | Q43050091 | ||
| Liver disease and cirrhosis because of Khat chewing in UK Somali men: a case series | Q43090480 | ||
| Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis | Q43550421 | ||
| Diagnosis and treatment of autoimmune hepatitis | Q44080061 | ||
| Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis | Q44086661 | ||
| The role of liver biopsy in the diagnosis of autoimmune hepatitis | Q44290701 | ||
| Characteristics of autoimmune hepatitis in Taiwan: the 11 years' experiences of a medical center. | Q44361260 | ||
| Simplified criteria for the diagnosis of autoimmune hepatitis | Q44425899 | ||
| Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis | Q44493542 | ||
| Clinical features of Japanese male patients with type 1 autoimmune hepatitis | Q44503303 | ||
| Frequency and significance of antibodies to chromatin in autoimmune hepatitis | Q44553038 | ||
| Autoimmune hepatitis triggered by Brucella infection or doxycycline or both | Q44608077 | ||
| High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis | Q44714980 | ||
| Atorvastatin as a trigger of autoimmune hepatitis | Q44805406 | ||
| LKM3 autoantibodies in hepatitis C cirrhosis: a further phenomenon of the HCV-induced autoimmunity | Q45205766 | ||
| Autoimmune hepatitis induced by the prolonged hepatitis A virus infection. | Q45393605 | ||
| Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa. | Q45768672 | ||
| Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis | Q45776652 | ||
| Liver/kidney microsome antibody type 1 and hepatitis C virus infection | Q45872748 | ||
| Adalimumab-induced autoimmune hepatitis. | Q45932142 | ||
| Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis. | Q45963125 | ||
| High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis | Q45998281 | ||
| Clinical features of antinuclear antibodies-negative type 1 autoimmune hepatitis | Q46215718 | ||
| Mycophenolate mofetil as second line therapy in autoimmune hepatitis? | Q46317682 | ||
| Budesonide in previously untreated autoimmune hepatitis. | Q46702694 | ||
| Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis | Q46847236 | ||
| The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease | Q47249864 | ||
| Pregnancy in autoimmune hepatitis: outcome and risk factors | Q47858204 | ||
| Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery | Q47863504 | ||
| Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis | Q48758554 | ||
| Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients | Q74346215 | ||
| Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy | Q74424827 | ||
| Acute hepatitis in a patient using a Chinese herbal tea--a case report | Q74425879 | ||
| Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview | Q74529379 | ||
| Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis | Q74637187 | ||
| Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy | Q77058192 | ||
| Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis | Q77694199 | ||
| Incidence of circulating antinuclear antibodies in cancer patients | Q79090617 | ||
| [Serological markers of arthritis in patients with chronic viral hepatitis] | Q80054090 | ||
| Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre | Q80087406 | ||
| Antifilamentous actin antibodies by ELISA for the diagnosis of type 1 autoimmune hepatitis | Q80297666 | ||
| Anti-alpha-actinin antibodies cross-react with anti-ssDNA antibodies in active autoimmune hepatitis | Q80497773 | ||
| Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease | Q80720176 | ||
| Disease-specific autoantibodies in patients with acute liver failure: the King's College London Experience | Q80788168 | ||
| Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group | Q80820259 | ||
| [Two cases of Wilson disease diagnosed as autoimmune hepatitis] | Q81030668 | ||
| Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis | Q81545428 | ||
| Anti-α actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1 | Q82325135 | ||
| Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients | Q82344181 | ||
| Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly | Q82640069 | ||
| Features and consequences of untreated type 1 autoimmune hepatitis | Q82661355 | ||
| Acute hepatitis induced by Chinese hepatoprotective herb, xiao-chai-hu-tang | Q82999297 | ||
| [Hepatitis C-autoimmune hepatitis overlap syndrome: five new cases] | Q83322059 | ||
| Incidence and Prevalence of Primary Biliary Cirrhosis, Primary Sclerosing Cholangitis, and Autoimmune Hepatitis in a Norwegian Population | Q50628941 | ||
| Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis. | Q50642440 | ||
| Autoimmune hepatitis associated with the use of black cohosh: a case study | Q50748562 | ||
| Prognosis of histological cirrhosis in type 1 autoimmune hepatitis | Q51035941 | ||
| Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis | Q51244795 | ||
| Liver transplantation for autoimmune hepatitis: a single-center experience. | Q51752178 | ||
| Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases | Q51809274 | ||
| Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis | Q51865630 | ||
| Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute-onset autoimmune hepatitis | Q53150319 | ||
| Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease | Q53191503 | ||
| Performance parameters of the diagnostic scoring systems for autoimmune hepatitis | Q53207120 | ||
| Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis | Q53240102 | ||
| Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome | Q53271951 | ||
| Autoimmune hepatitis in childhood: a 20-year experience | Q53361457 | ||
| The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization | Q53390835 | ||
| Prevalence of positive antinuclear antibodies in healthy children | Q53651701 | ||
| Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis | Q53741912 | ||
| Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis | Q53888400 | ||
| Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP) | Q53914094 | ||
| Development of cytochrome P450 2D6-specific LKM-autoantibodies following liver transplantation for Wilson's disease -- possible association with a steroid-resistant transplant rejection episode | Q54085100 | ||
| Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis | Q54549498 | ||
| Autoimmune Hepatitis | Q56210456 | ||
| Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis | Q56906375 | ||
| Positive and negative regulation of human T cell activation mediated by the CTLA-4/CD28 ligand CD80 | Q56907477 | ||
| Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1 | Q57007229 | ||
| Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease | Q57062009 | ||
| Drug induced liver injury and its relationship to autoimmune hepatitis | Q58130836 | ||
| Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2 | Q58852141 | ||
| New insights into autoimmune liver diseases | Q59384468 | ||
| Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: A nationwide study | Q59490154 | ||
| Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I | Q61960547 | ||
| Response to steroids in de novo autoimmune hepatitis after liver transplantation | Q62616297 | ||
| HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients | Q67519806 | ||
| Diagnostic value of anti-F-actin antibodies in a French multicenter study | Q40398181 | ||
| Deflazacort for long-term maintenance of remission in type I autoimmune hepatitis. | Q40795948 | ||
| New challenges in hepatic fibrosis | Q40829825 | ||
| Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2. | Q41030864 | ||
| Diagnosis and therapy of autoimmune liver disease | Q41109690 | ||
| Classification of smooth muscle autoantibodies detected by immunofluorescence | Q41243939 | ||
| Autoimmune hepatitis triggered by administration of an herbal medicine. | Q41452637 | ||
| Elevated serum immunoglobulin G levels in patients with chronic liver disease in comparison to patients with autoimmune hepatitis | Q42014772 | ||
| Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. | Q42630836 | ||
| Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. | Q42693140 | ||
| Drug-induced autoimmune hepatitis caused by anti-tumor necrosis factor α agents. | Q42935467 | ||
| Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis. | Q42941782 | ||
| Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition | Q27485138 | ||
| Zhonghua yi xue za zhi | Q27710254 | ||
| An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21 | Q28242410 | ||
| Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy | Q28362587 | ||
| Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis | Q29619713 | ||
| Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis | Q30982605 | ||
| Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature | Q33371491 | ||
| Long-term treatment outcomes for autoimmune hepatitis in Korea | Q33565469 | ||
| Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. | Q33665767 | ||
| Difficult treatment decisions in autoimmune hepatitis | Q33688293 | ||
| Pathogenesis of autoimmune hepatitis | Q33698264 | ||
| International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis | Q33784003 | ||
| Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis | Q33914734 | ||
| JC virus DNA sequences are frequently present in the human upper and lower gastrointestinal tract. | Q33923296 | ||
| Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management | Q33977201 | ||
| Range of antinuclear antibodies in “healthy” individuals | Q34065272 | ||
| Diagnosis and management of autoimmune hepatitis | Q34118165 | ||
| Autoantibodies in liver disease | Q34157056 | ||
| Smooth muscle antibodies and type 1 autoimmune hepatitis | Q34199651 | ||
| LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase | Q34205552 | ||
| Autoimmune overlap syndromes | Q34205699 | ||
| Genetic distinctions between autoimmune hepatitis in Italy and North America | Q34406835 | ||
| Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection | Q34408327 | ||
| Serum autoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on the disease profile | Q34439843 | ||
| Autoimmune hepatitis: Single-center experience of clinical presentation, response to treatment and prognosis in Saudi Arabia | Q34469059 | ||
| Long-term follow-up of chronic active hepatitis of moderate severity | Q34474401 | ||
| Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis | Q34545376 | ||
| Hepatocellular carcinoma in patients with autoimmune hepatitis. | Q34604173 | ||
| CD3-specific antibodies: a portal to the treatment of autoimmunity | Q34654024 | ||
| Liver injuries induced by herbal medicine, Syo-saiko-to (xiao-chai-hu-tang) | Q34721069 | ||
| Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. | Q34782167 | ||
| Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis | Q67555835 | ||
| Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis | Q67743320 | ||
| Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2 | Q67970209 | ||
| Anti-liver-kidney microsome antibody-positive autoimmune hepatitis presenting as fulminant liver failure | Q68890876 | ||
| Hepatic Disorders Associated with Liver/Kidney Microsomal Antibodies | Q69342776 | ||
| Characterization of the microsomal antigen related to a subclass of active chronic hepatitis | Q69355004 | ||
| Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis | Q69544750 | ||
| Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen | Q69893348 | ||
| Antibody to smooth muscle in patients with liver disease | Q70060514 | ||
| Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis | Q70146489 | ||
| Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent | Q70280999 | ||
| Meeting report: International Autoimmune Hepatitis Group | Q70496892 | ||
| Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases | Q70588163 | ||
| Autoimmune hepatitis | Q70868063 | ||
| Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis | Q71039699 | ||
| HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies | Q71211594 | ||
| Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis | Q71506734 | ||
| Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis | Q71748722 | ||
| Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes | Q71818738 | ||
| Azathioprine for Long-Term Maintenance of Remission in Autoimmune Hepatitis | Q72039839 | ||
| Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis | Q72164385 | ||
| Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis | Q72591135 | ||
| Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis | Q72816115 | ||
| Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis | Q73130778 | ||
| Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitis | Q73434754 | ||
| [Absorption of L. E. factor by isolated cell nuclei] | Q73560726 | ||
| Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study | Q73568156 | ||
| Duration of immunosuppressive therapy in autoimmune hepatitis | Q73700106 | ||
| Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis | Q73712017 | ||
| Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay | Q73738516 | ||
| Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases | Q73876496 | ||
| Genetic distinctions between types 1 and 2 autoimmune hepatitis | Q73943211 | ||
| Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1 | Q74133466 | ||
| Antibodies to soluble liver antigen: specific marker of autoimmune hepatitis | Q74203514 | ||
| Lupoid hepatitis | Q74334969 | ||
| Prevalence and epidemiology of autoimmune hepatitis | Q34936597 | ||
| Autoimmune Hepatitis: A Review of Current Diagnosis and Treatment | Q35094267 | ||
| Autoimmune liver disease - are there spectra that we do not know? | Q35230369 | ||
| Antimitochondrial and other autoantibodies | Q35573899 | ||
| Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis | Q35621266 | ||
| Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis | Q35769853 | ||
| Autoantibodies in autoimmune liver disease | Q36342548 | ||
| Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis | Q36570658 | ||
| The regulatory effect of natural killer cells: do "NK-reg cells" exist? | Q36595289 | ||
| Recurrence of autoimmune liver disease after liver transplantation: a systematic review | Q36619493 | ||
| The validity and importance of subtypes in autoimmune hepatitis: a point of view | Q36690069 | ||
| Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis | Q36744611 | ||
| Animal models for autoimmune hepatitis. | Q36782366 | ||
| Hepatitis A vaccine associated with autoimmune hepatitis | Q36804325 | ||
| Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly | Q37106402 | ||
| Favorable outcomes of autoimmune hepatitis in a community clinic setting | Q37121827 | ||
| The use of budesonide in the treatment of autoimmune hepatitis in Canada | Q37139335 | ||
| Autoimmune paediatric liver disease | Q37182955 | ||
| Overlap syndromes among autoimmune liver diseases | Q37182958 | ||
| A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis | Q37202406 | ||
| Liver involvement in systemic lupus erythematosus: case review of 40 patients | Q37269331 | ||
| Autoimmune hepatitis and liver transplantation: indications, results, and management of recurrent disease | Q37579109 | ||
| Special clinical challenges in autoimmune hepatitis: the elderly, males, pregnancy, mild disease, fulminant onset, and nonwhite patients | Q37579114 | ||
| Review article: the modern management of autoimmune hepatitis | Q37680001 | ||
| Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials | Q37733093 | ||
| Drug-induced liver injury: past, present and future. | Q37736444 | ||
| Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis | Q37745609 | ||
| Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy | Q37903855 | ||
| Characteristics of autoimmune hepatitis in the Asia-Pacific Region: historical review | Q37948679 | ||
| Advances in the Current Treatment of Autoimmune Hepatitis | Q38000056 | ||
| Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition | Q38318118 | ||
| Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial/anti-M2 seropositive variant form of autoimmune hepatitis. | Q38999540 | ||
| Chloroquine for the maintenance of remission of autoimmune hepatitis: results of a pilot study | Q39278084 | ||
| Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders | Q40028248 | ||
| Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study. | Q40286971 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| autoimmune hepatitis | Q786844 | ||
| P304 | page(s) | 312817 | |
| P577 | publication date | 2012-12-12 | |
| P1433 | published in | Autoimmune Diseases | Q26842451 |
| P1476 | title | Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview | |
| Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview | |||
| P478 | volume | 2012 |
| Q90354283 | "Let my liver rather heat with wine" - a review of hepatic fibrosis pathophysiology and emerging therapeutics |
| Q35954255 | Autoimmune Hepatitis in Hawai'i |
| Q35906055 | Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of Disease |
| Q26991971 | Autoimmune hepatitis in childhood: The role of genetic and immune factors |
| Q91841670 | The Saudi association for the study of liver diseases and transplantation clinical practice guidelines for management of autoimmune hepatitis |
| Q52625742 | Translocation of a gut pathobiont drives autoimmunity in mice and humans. |
Search more.